COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,903 Articles (22,568 medRxiv, 8,335 bioRxiv)

Most recent first Previous |  Page 160: Articles 1591-1600  | Next

Reactogenicity Differences between COVID-19 Vaccines: A Prospective Observational Study in the United States and Canada
Rousculp, M. D., Hollis, K., Ziemiecki, R., Odom, D., Marchese, A. M., Montazeri, M., Odak, S., Jackson, L., Beyhaghi, H., Toback, S.
10.1101/2024.06.25.24309259 — Posted: 2024-06-25
Challenges facing Canadian Long-Term Care Homes and Retirement Homes during the COVID-19 pandemic
Fahim, C., Hassan, A. T., Quinn de Launay, K., Takaoka, A., Togo, E., Strifler, L., Bach, V., Paul, N., Mrazovac, A., Firman, J., Gruppuso, V., Boyd, J. M., Straus, S.
10.1101/2024.06.19.24308949 — Posted: 2024-06-24
Digital Immunoassay for Rapid Detection of SARS-CoV-2 Infection in a Broad Spectrum of Animals
Li, S., Wang, W., Liu, W., Chen, C., Shephard, S., Yuan, F., Reinhart, J. M., Diel, D., Cunningham, B., Fang, Y.
10.1101/2024.06.21.600129 — Posted: 2024-06-24
ACE-2 Blockade & TMPRSS2 Inhibition Mitigate SARS-CoV-2 Severity Following Cigarette Smoke Exposure in Airway Epithelial Cells In Vitro
Hussain, S. S., Libby, E. F., Lever, J. E. P., Tipper, J. L., Phillips, S. E., Mazur, M., Li, Q., Campos-Gomez, J., Harrod, K. S., Rowe, S. M.
10.1101/2024.06.23.600238 — Posted: 2024-06-24
Cellular sialoglycans are differentially required for endosomal and cell-surface entry of SARS-CoV-2
Siwak, K. C., LeBlanc, E. V., Scott, H. M., Kim, Y., Pellizzari-Delano, I. E., Ball, A. M., Temperton, N. J., Capicciotti, C. J., Colpitts, C. C.
10.1101/2024.06.24.600376 — Posted: 2024-06-24
EEG Signatures of COVID-19 Survival compared to close contacts and the Cuban EEG normative database
Calzada-Reyes, A., Galan-Garcia, L., Virues-Alba, T., Charroo-Ruiz, L. E., Perez-Mayo, L., Bringas Vega, M. L., Ren, P., Bosh-Bayard, J., Acosta-Imas, Y., Vega-Hernandez, M., Ontiveros-Ortega, M., Perodin Hernandez, J., Aubert-Vazquez, E., Paz-Linares, D., Gutierrez-Gil, J., Caballero-Moreno, A., Valdes-Virues, A., Valdes-Sosa, M., Rodriguez-Labrada, R., Valdes-Sosa, P. A.
10.1101/2024.06.21.600102 — Posted: 2024-06-24
Refinement of post-COVID condition core symptoms, subtypes, determinants, and health impacts: A cohort study integrating real-world data and patient-reported outcomes
Wang, Y., Alcalde-Herraiz, M., Lopez Guell, K., Chen, L., Mateu, L., Li, C., Ali, R., Wareham, N., Paredes, R., PRIETO-ALHAMBRA, D., Xie, J.
10.1101/2024.06.23.24309348 — Posted: 2024-06-24
Temporal multi-omic analysis of COVID-19 in end-stage kidney disease
Stephenson, E., Macdonald-Dunlop, E., Dratva, L. M., Lindeboom, R. G. H., Tuong, Z. K., Tun, W. M., Buang, N. B., Ballereau, S., Cabantaus, M., Penalver, A., Prigmore, E., Ferdinand, J. R., Stewart, B. J., Gisby, J., Malik, T., Clarke, C. L., Medjeral-Thomas, N., Prendecki, M., McAdoo, S., Portet, A., Willicombe, M., Sandhu, E., Pickering, M. C., Botto, M., Teichmann, S. A., Haniffa, M., Clatworthy, M. R., Thomas, D. C., Peters, J. E.
10.1101/2024.06.20.24309228 — Posted: 2024-06-24
Determinants of SARS-CoV-2 within-host evolutionary rates in persistently infected individuals
Ghafari, M., Kemp, S. A., Hall, M., Clarke, J., Ferretti, L., Thomson, L., Studley, R., Rourke, E., COVID-19 Infection Survey Group, , The COVID-19 Genomics UK (COG-UK) Consortium, , Walker, A. S., Golubchik, T., Lythgoe, K.
10.1101/2024.06.21.24309297 — Posted: 2024-06-22
POST-ACUTE SEQUELAE OF COVID-19: CHARACTERIZATION, COMORBIDITIES, AND BIOMARKERS IN A DIVERSE COHORT
Struttmann, E., Shah, A., Moreida, M., Rubin, M., Immel, S., Patel, U., Chatwani, B., Flaherty, S., Liu, S., Theberge, M., Lockhart, A., Nguyen, C., Montes, J., Katz, J., Drouin, A., Fusco, D.
10.1101/2024.06.20.24308901 — Posted: 2024-06-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).